Inventor · disambiguated record
Vincent P. Sandanayaka
Also filed as: SANDANAYAKA VINCENT · SANDANAYAKA VINCENT P · SANDANAYAKA VINCENT PREMARATNA
41 granted patents·14 pending applications·562 citations·filing 2000–2023
98Inventor score
Files withKARYOPHARM THERAPEUTICS INC18DECODE GENETICS EHF8BIOGEN MA INC6WYETH CORP5NIROGY THERAPEUTICS INC3
Top patents by PatentIndex Score
55 records- 0198US11787771B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·5 cites·12 claims
- 0297US12291508B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted May 6, 2025·2 cites·15 claims
- 0397US11034660B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 0497US10335393B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Jul 2, 2019·20 cites·12 claims
- 0597US10173987B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·18 cites·12 claims
- 0697US10058535B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2017·Granted Aug 28, 2018·24 cites·1 claims
- 0797US9861614B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·27 cites·19 claims
- 0897US9714226B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·28 cites·8 claims
- 0997US9585874B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·27 cites·19 claims
- 1097US9266843B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·31 cites·6 claims
- 1197US9206158B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·28 cites·2 claims
- 1297US9096543B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·35 cites·35 claims
- 1397US8999996B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·44 cites·2 claims
- 1496US10544108B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·14 cites·7 claims
- 1596US9079865B2Hydrazide containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Jul 14, 2015·38 cites·13 claims
- 1694US10722497B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2019·Granted Jul 28, 2020·3 cites·26 claims
- 1793US9550757B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Jan 24, 2017·24 cites·25 claims
- 1892US10617677B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2018·Granted Apr 14, 2020·3 cites·18 claims
- 1992US9428490B2Nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Aug 30, 2016·27 cites·8 claims
- 2092US9303000B2Olefin containing nuclear transport modulators and uses thereofSANDANAYAKA VINCENT P·Filed 2012·Granted Apr 5, 2016·28 cites·10 claims
- 2192US8513230B2Nuclear transport modulators and uses thereofSHACHAM SHARON·Filed 2011·Granted Aug 20, 2013·39 cites·7 claims
- 2292US7674802B2N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammationDECODE GENETICS EHF·Filed 2006·Granted Mar 9, 2010·10 cites·8 claims
- 2389US7626023B2Compounds for treating tumorsWYETH CORP·Filed 2008·Granted Dec 1, 2009·12 cites·13 claims
- 2486US7750012B2Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammationDECODE GENETICS EHF·Filed 2006·Granted Jul 6, 2010·9 cites·23 claims
- 2585US10925859B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2020·Granted Feb 23, 2021·1 cites·21 claims
- 2685US7402684B2Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammationDECODE GENECTICS EHF·Filed 2006·Granted Jul 22, 2008·15 cites·29 claims
- 2785US7390910B2Compounds for treating tumorsWYETH CORP·Filed 2004·Granted Jun 24, 2008·14 cites·45 claims
- 2883US2024376114A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2979US8791267B2Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersSINGH JASBIR·Filed 2012·Granted Jul 29, 2014·4 cites·22 claims
- 3078US11318120B2Nuclear transport modulators and uses thereofBIOGEN MA INC·Filed 2021·Granted May 3, 2022·0 cites·6 claims
- 3177US6358980B1Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Mar 19, 2002·8 cites·5 claims
- 3276US6753337B2Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitorsWYETH CORP·Filed 2001·Granted Jun 22, 2004·5 cites·5 claims
- 3373US8883833B2Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersSINGH JASBIR·Filed 2008·Granted Nov 11, 2014·1 cites·28 claims
- 3472US2022056038A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3570US2023192718A1Bicyclic enone carboxylates as modulators of transporters and uses thereofNIROGY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3667US8598359B2Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammationSANDANAYAKA VINCENT·Filed 2008·Granted Dec 3, 2013·1 cites·13 claims
- 3767US7282496B2Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitorsWYETH CORP·Filed 2002·Granted Oct 16, 2007·3 cites·15 claims
- 3867US6489316B26-(spirocyclopropyl) penicillanic acid 4, 4-dioxidesAMERICAN CYANAMID CO·Filed 2001·Granted Dec 3, 2002·4 cites·38 claims
- 3964US2009324569A1Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disordersDECODE GENETICS EHF·Filed 2008·Application pending·0 cites
- 4063US2020087313A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4161US2014301999A1Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disordersDECODE GENETICS EHF·Filed 2014·Application pending·0 cites
- 4260US2022249454A1Inhibitors of monocarboxylate transporters for cancer immunotherapyNIROGY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4359US7576102B2Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammationDECODE GENETICS EHF·Filed 2006·Granted Aug 18, 2009·0 cites·11 claims
- 4458US2009233969A1Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammationDECODE GENETICS EHF·Filed 2009·Application pending·0 cites
- 4557US2017137430A1Nuclear Transport Modulators And Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4656US2021053982A1Bicyclic enone carboxylates as modulators of transporters and uses thereofNIROGYONE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4753US2022281888A1Bicyclic carboxylates as modulators of transporters and uses thereofNIROGY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4850US2004229924A1Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/TACE inhibitorsWYETH CORP·Filed 2004·Application pending·0 cites
- 4948US8877816B24-(or 5-) substituted catechol derivativesSINGH JASBIR·Filed 2008·Granted Nov 4, 2014·0 cites·29 claims
- 5047US7728032B2Phenoxymethylalkyne inhibitors of LTA4H for treating inflammationDECODE GENETICS EHF·Filed 2007·Granted Jun 1, 2010·0 cites·5 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →